CytoMed Therapeutics Limited (GDTC)
CytoMed Therapeutics Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
CytoMed Therapeutics Limited (GDTC) is a Biotechnology company based in SG with a market capitalization of $11.5M. Revenue grew 513.8% year-over-year and free cash flow was negative at -$4.4M. This page tracks GDTC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
SG · 43 employees · IPO Apr 14, 2023
Valuation
Valuation & price
$1.16as of May 26, 2026· -56.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$11.5M
Market cap
513.8%
Revenue growth (YoY)
-277.7%
Gross margin
-$4.4M
Free cash flow (USD)
-$1.6M
Net debt
Net cash position
0.9%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
3
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jun 30, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider buyJul 24, 2026Filing
Insider Buy $300KChoo Chee Kong · Director, 10% Owner · $300K
- Insider buyJul 24, 2026Filing
Insider Buy $300KChoo Chee Kong · Director, 10% Owner · $300K
- 6-K filingJun 23, 2026Filing
Share Purchase Agreement
- Insider buyJun 15, 2026Filing
Insider Buy $129KChoo Chee Kong · Director, 10% Owner · $128.8K
- Annual reportJun 3, 2026Filing
Annual Report Filed
- 6-K filingMay 15, 2026Filing
Management Change
- 6-K filingMay 11, 2026Filing
Name Change Announcement
- Annual reportApr 14, 2026Filing
Annual Report Filed
Questions
Frequently asked questions
What is CytoMed Therapeutics Limited's market cap?
CytoMed Therapeutics Limited (GDTC) has a market capitalization of $11.5M.
What is GDTC's P/E ratio?
A meaningful P/E ratio is not available for GDTC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did CytoMed Therapeutics Limited last report earnings?
GDTC last reported earnings on June 30, 2026; the next date is not yet scheduled.
Are insiders buying GDTC stock?
Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at CytoMed Therapeutics Limited in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.